COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2023

Feb 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2023-02-10

Reporting Person: Tupper Colleen (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-10	Common Stock	A	45045	—	Acquired	135349	Direct
2023-02-10	Common Stock	A	12565	—	Acquired	147914	Direct
2023-02-10	Common Stock	F	6967	$26.75	Disposed	140947	Direct
2023-02-10	Common Stock	F	3887	$26.75	Disposed	137060	Direct

Footnotes

F1: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

F2: Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years.

F3: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

F4: Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.